Cadrenal Therapeutics, Inc Common Stock
Price & Volume
Stats
See moreOpen | $1.30 |
Previous Close | $1.32 |
Day Range | $1.22-$1.32 |
52W Range | $1-$14.63 |
Market Cap | $4.7M |
Shares Short | 86,862 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$4.88 |
News
See moreYahoo Finance • 22 days ago
Cadrenal Therapeutics to Participate in H.C. Wainwright's 28th Annual Global Investment Conference
Yahoo Finance • 2 months ago
Weekly Buzz: NVS, MRK Win FDA Nod; LLY Snaps Up ATAI; MANE Shines On Hair Loss Data
Yahoo Finance • 3 months ago
Cadrenal Therapeutics Announces up to $8.8 Million Private Placement Priced At-The-Market Under Nasdaq Rules
Yahoo Finance • 3 months ago
Cadrenal Therapeutics to File for FDA Rare Pediatric Disease Designation for Tecarfarin in Kawasaki Disease
About
CEO | Mr. Quang X. Pham |
CFO | Mr. John P. Sharp CPA |
Address | 822 A1A North, Ponte Vedra, FL, United States, 32082 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 5 |